Cost and effectiveness of lung lobectomy by video-assisted thoracic surgery for lung cancer

Background: Video-assisted thoracic surgery (VATS) emerged as a minimally invasive surgery for diseases in the field of thoracic surgery. We herein reviewed our experience on thoracoscopic lobectomy for early lung cancer and evaluated Health System use. Methods: A cost-effectiveness study was perfor...

Descripción completa

Detalles Bibliográficos
Autores: MAFÉ, J., Planelles B, ASENSIO, S., CEREZAL, J., INDA, M., Lacueva J, Esteban MD, MARTIN, C., BASCHWITZ, B.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p4462
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/4462
Access Level:acceso abierto
Palabra clave:Video-assisted thoracic surgery (VATS)
open thoracic surgery
pulmonary function tests
surgery lobectomy
lung cancer
Descripción
Sumario:Background: Video-assisted thoracic surgery (VATS) emerged as a minimally invasive surgery for diseases in the field of thoracic surgery. We herein reviewed our experience on thoracoscopic lobectomy for early lung cancer and evaluated Health System use. Methods: A cost-effectiveness study was performed comparing VATS vs. open thoracic surgery (OPEN) for lung cancer patients. Demographic data, tumor localization, dynamic pulmonary function tests [forced vital capacity (FVC), forced expiratory volume in one second (FEV1), diffusion capacity (DLCO) and maximal oxygen uptake (VO2max)], surgical approach, postoperative details, and complications were recorded and analyzed. Results: One hundred seventeen patients underwent lung resection by VATS (n=42, 36%; age: 63 +/- 9 years old, 57% males) or OPEN (n=75, 64%; age: 61 +/- 11 years old, 73% males). Pulmonary function tests decreased just after surgery with a parallel increasing tendency during first 12 months. VATS group tended to recover FEV1 and FVC quicker with significantly less clinical and post-surgical complications (31% vs. 53%, P=0.015). Costs including surgery and associated hospital stay, complications and costs in the 12 months after surgery were significantly lower for VATS (P<0.05). Conclusions: The VATS approach surgery allowed earlier recovery at a lower cost than OPEN with a better cost-effectiveness profile.